Arch Biopartners Inc. (ACHFF)
OTCMKTS · Delayed Price · Currency is USD
0.6804
-0.0596 (-8.05%)
Sep 8, 2026, 3:24 PM EST
Arch Biopartners Market Cap
Arch Biopartners has a market cap or net worth of $50.27 million as of September 8, 2026. Its market cap has decreased by -37.67% in one year.
Market Cap
50.27M
Enterprise Value
52.19M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.68
ChartMarket Cap Chart
Since January 21, 2011, Arch Biopartners's market cap has increased from 33.63M to 50.27M, an increase of 49.50%. That is a compound annual growth rate of 2.61%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 4, 2026 | 50.27M | -14.98% |
| Dec 31, 2025 | 59.13M | -32.56% |
| Dec 31, 2024 | 87.67M | 25.12% |
| Dec 29, 2023 | 70.07M | -46.02% |
| Dec 30, 2022 | 129.79M | -23.83% |
| Dec 31, 2021 | 170.40M | 138.05% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 26, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 26, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 23, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Vaxart | 120.20M |
| HST Global | 91.93M |
| NDT Pharmaceuticals | 80.25M |
| Sangamo Therapeutics | 66.70M |
| Nuo Therapeutics | 58.60M |
| BetterLife Pharma | 35.87M |
| Cell Source | 35.13M |
| Vicapsys Life Sciences | 32.37M |